This High-Flying Stock Just Became a Better Buy

It might not be too late to get in on the party. If there were a "revelation of the year" award for each industry on the stock market, Viking Therapeutics (VKTX -2.18%) would be a leading contender for the biotech sector. The mid-cap drugmaker impressed investors with promising clinical progress in the hottest therapeutic area in the industry: weight loss. Viking has been rewarded. The company's shares are up substantially year to date. However, recent developments, some of which the company revealed in its ...